Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection

Journal of Neuroimmunology

Volumn 76, Issue 1-2, 1997, Pages 213-223

  Sato, Shigeru ^a   Reiner, Steven L ^b   Jensen, Mark A ^a   Roos, Raymond P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cytokines; Experimental allergic encephalomyelitis; In vivo animal models; Multiple sclerosis; Theiler's murine encephalomyelitis virus

Indexed keywords

CYTOKINE; MESSENGER RNA;

ALLERGIC ENCEPHALITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DEMYELINATION; HELPER CELL; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; POLIOMYELITIS; PRIORITY JOURNAL;

ANIMALS; BRAIN; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENOME, VIRAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; POLIOMYELITIS; RNA, MESSENGER; SPINAL CORD; THEILOVIRUS;

EID: 0030911059     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00059-3     Document Type: Article

References (57)

1. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Jr. Surface expression of α4 integrin by CD4 T-cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
2. Bi Z., Quandt P., Komatsu T., Barna M., Reiss C.S. IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system. J. Immunol. 155:1995;5684-5689.
3. Campbell I.L., Hobbs M.V., Kemper P., Oldstone M.B.A. Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J. Immunol. 152:1994;716-723.
4. Clatch R.J., Lipton H.L., Miller S.D. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: Correlation with clinical signs. J. Immunol. 136:1986;920-927.
5. Clatch R.J., Melvold R.W., Miller S.D., Lipton H.L. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: Correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 135:1985;1408-1414.
6. Dal Canto M.C., Lipton H.L. Primary demyelination in Theiler's virus infection: An ultrastructural study. Lab. Invest. 33:1975;626-637.
7. + T-cells protect against demyelination. Ann. Neurol. 40:1996;517-518. Abstract.
8. Fiette L., Aubert C., Brahic M., Rossi C.P. Theiler's virus infection of β2-microglobulin-deficient mice. J. Virol. 67:1993;589-592.
9. Fiette L., Aubert C., Müller U., Huang S., Aguet M., Brahic M., Bureau J.F. Theiler's virus infection of 129Sv mice that lack the interferon α/β or interferon γ receptors. J. Exp. Med. 181:1995;2069-2076.
10. Fiette L., Brahic M., Pena-Rossi C. Infection of class II-deficient mice by the DA strain of Theiler's virus. J. Virol. 70:1996;4811-4815.
11. Gerety S.J., Rundell M.K., Dal Canto M.C., Miller S.D. Class II-restricted T-cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T-cell line specific for an immunodominant VP2 epitope. J. Immunol. 152:1994;919-929.
12. Hafler D.A., Weiner H.L. Immunologic mechanisms and therapy in multiple sclerosis. Immunol. Rev. 144:1995;75-107.
13. Hopkins S.J., Rothwell N. Cytokines and the nervous system I: Expression and recognition. Trends Neurosci. 18:1995;83-88.
14. Issazadeh S., Ljungdahl Å., Höjeberg B., Mustafa M., Olsson T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: Dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β J. Neuroimmunol. 61:1995;205-212.
15. Issazadeh S., Lorentzen J.C., Mustafa M.I., Höjeberg B., Müssener Å., Olsson T. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: Persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-β J. Neuroimmunol. 69:1996;103-115.
16. Issazadeh S., Mustafa M., Ljungdahl Å., Höjeberg B., Dagerlind Å., Elde R., Olsson T. Interferon γ, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in Lewis rats: Dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J. Neurosci. Res. 40:1995;579-590.
17. + Th1 but not Th2 cytokine responses. Int. Immunol. 6:1994;721-730.
18. Karpus W.J., Pope J.G., Peterson J.D., Dal Canto M.C., Miller S.D. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J. Immunol. 155:1995;947-957.
19. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:1992;2496-2505.
20. Khoury S.J., Hancock W.W., Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4 and prostaglandin E expression in the brain. J. Exp. Med. 176:1992;1355-1364.
21. Lindsley M.D., Rodriguez M. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J. Immunol. 142:1989;2677-2682.
22. Lipton H.L., Dal Canto M.C. Theiler's virus-induced demyelination: Prevention by immunosuppression. Science. 192:1976;62-64.
23. Lipton H.L., Dal Canto M.C. Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect. Immun. 26:1979;174-369.
24. Merrill J.E., Kono D.H., Clayton J., Ando D.G., Hinton D.R., Hofman F.M. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10 PL mice. Proc. Natl. Acad. Sci. USA. 89:1992;574-578.
25. Miller S.D., Karpus W.J. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol. Today. 15:1994;356-361.
26. Miller S.D., McRae B.L., Vanderlugt C.L., Nikcevich K.M., Pope J.G., Pope L., Karpus W.J. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol. Rev. 144:1995;225-244.
27. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138-146.
28. Nicholson S.M., Peterson J.D., Miller S.D., Wang K., Dal Canto M.C., Melvold R.W. BALB/c substrain differences in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Neuroimmunol. 52:1994;19-24.
29. Njenga M.K., Pavelko K.D., Baisch J., Lin X., David C., Leibowitz J., Rodriguez M. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J. Virol. 70:1996;1729-1737.
30. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:1995;245-268.
31. Orange J.S., Salazar-Mather T.P., Opal S., Spencer R.L., Miller A.H., McEwen B.S. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:1995;901-914.
32. Orange J.S., Wolf S.F., Biron C.A. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1994;1253-1264.
33. Paya C.V., Leibson P.J., Patick A.K., Rodriguez M. Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. Int. Immunol. 2:1990;909-913.
34. Peterson J.D., Karpus W.J., Clatch R.J., Miller S.D. Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur. J. Immunol. 23:1993;46-55.
35. Peterson J.D., Waltenbaugh C., Miller S.D. IgG subclass responses to Theiler's murine encephalomyelitis virus infection and immunization suggest a dominant role for Th1 cells in susceptible mouse strains. Immunology. 75:1992;652-658.
36. Pullen L.C., Miller S.D., Dal Canto M.C., Kim B.S. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T-cell response to viral antigens and susceptibility to demyelination. Eur J. Immunol. 23:1993;2287-2293.
37. Reiner S.L., Zheng S., Corry D.B., Locksley R.M. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods. 165:1993;37-46.
38. b mice deficient in β2-microglobulin. J. Immunol. 151:1993;266-276.
39. Rodriguez M., Lindsley M.D. Immunosuppression promotes CNS remyelination in chronic virus-induced demyelinating disease. Neurology. 42:1992;348-357.
40. Rodriguez M., Pavelko K., Coffman R.L. Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J. Virol. 69:1995;7286-7290.
41. Rodriguez M., Pavelko K.D., McKinney C.W., Leibowitz J.L. Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J. Immunol. 153:1994;3811-3821.
42. Roos, R.P., Casteel, N., 1992. Determinants of neurological disease induced by Theiler's murine encephalomyelitis virus. In: Roos, R.P. (Ed.), Molecular Neurovirology, Humana Press, Totowa, NJ, pp. 283-318.
43. Roos R.P., Firestone S., Wollmann R., Variakojis D., Arnason B.G.W. The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J. Neuroimmunol. 2:1982;223-234.
44. Roos R.P., Stein S., Ohara Y., Fu J., Semler B.L. Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus. J. Virol. 63:1989;5492-5496.
45. Roos R.P., Wollmann R. DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann. Neurol. 15:1984;494-499.
46. Rosenthal A., Fujinami R.S., Lampert P.W. Mechanism of Theiler's virus-induced demyelination in nude mice. Lab. Invest. 54:1986;515-522.
47. Rubio N., Capa L. Differential IL-1 synthesis by astrocytes from Theiler's murine encephalomyelitis virus-susceptible and -resistant strains of mice. Cell. Immunol. 149:1993;237-247.
48. Rubio N., Sierra A. Interleukin-6 production by brain tissue and cultured astrocytes infected with Theiler's murine encephalomyelitis virus. Glia. 9:1993;41-47.
49. Sharma D.P., Ramsay A.J., Maguire D.J., Rolph M.S., Ramshaw I.A. Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J. Virol. 70:1996;7103-7107.
50. Sierra A., Rubio N. Theiler's murine encephalomyelitis virus induces tumour necrosis factor-α in murine astrocyte cell cultures. Immunology. 78:1993;399-404.
51. Tsunoda I., Fujinami R.S. Two models for multiple sclerosis: Experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J. Neuropath. Exp. Neurol. 55:1996;673-686.
52. Van der Veen R.C., Kapp J.A., Trotter J.L. Fine-specificity differences in the recognition of an encephalitogenic peptide by T-helper 1 and 2 cells. J. Neuroimmonol. 48:1993;221-226.
53. Wesselingh S.L., Griffin D.E. Local cytokine responses during acute and chronic viral infections of the central nervous system. Semin. Virol. 5:1994;457-463.
54. Wesselingh S.L., Levine B., Fox R.J., Choi S., Griffin D.E. Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T-cell response. J. Immunol. 152:1994;1289-1297.
55. 233-244. J. Immunol. 153:1994;4508-4519.
56. Zamvil S.S., Mitchell D.J., Moore A.C., Schwarz A.J., Stiefel W., Nelson P.A., Rothbard J.B., Steinman L. T-cell specificity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein. J. Immunol. 139:1987;1075-1079.
57. Zhang L., Sato S., Kim J.I., Roos R.P. Theiler's virus as a vector for foreign gene delivery. J. Virol. 69:1995;3171-3175.